Description
KLOW is a fixed-ratio combination of four widely studied research peptides β KPV, GHK-Cu, BPC-157, and TB-500 β brought together in a single lyophilized vial. Each component contributes a distinct signaling profile: KPV, a tripeptide fragment of Ξ±-MSH, is studied for anti-inflammatory pathway activity; GHK-Cu, a copper-binding tripeptide, is examined for its role in extracellular matrix and tissue-remodeling signaling; BPC-157 is studied for angiogenic and cytoprotective activity; and TB-500 is researched for actin regulation and cell migration. In controlled laboratory settings, KLOW is examined for the combined receptor and signaling-pathway activity of its four components β positioning it as a comprehensive research blend for regenerative, anti-inflammatory, and tissue-remodeling studies.
Important Note
KLOW is not approved for human consumption, medical use, or diagnostic purposes. It is supplied strictly for laboratory research only. Handling should be performed by qualified professionals in an appropriate controlled research setting.
Dosage Reference Chart (Research Use Only)
| Form | Suggested Research Concentration | Example Preparation | Notes |
|---|---|---|---|
| Lyophilized Powder | 80mg per vial (GHK-Cu 50mg + KPV 10mg + BPC-157 10mg + TB-500 10mg) | Reconstitute with sterile or bacteriostatic water | Store dry at β20Β°C until use |
| Reconstituted Solution | 8β16 mg/mL | Dissolve to target concentration for experiments | Stable at 2β8Β°C for 2β3 weeks; do not freeze once reconstituted |
| Experimental Dosing | Variable by study | Adjust according to study design | Preclinical / literature-based models only |
Features & Properties
Four-peptide fixed-ratio blend: KPV, GHK-Cu, BPC-157, and TB-500 in one vial
KPV studied for anti-inflammatory pathway activity (Ξ±-MSH fragment)
GHK-Cu examined for extracellular matrix and tissue-remodeling signaling
BPC-157 studied for angiogenic and cytoprotective activity
TB-500 researched for actin regulation and cell migration
Examined for the combined signaling-pathway activity of all four components
Supplied as lyophilized powder with HPLC-verified purity β₯99%
Storage & Stability
Lyophilized: stable for up to 24 months at β20Β°C
Reconstituted solution: stable for 2β3 weeks at 2β8Β°C
Avoid repeated freezeβthaw cycles
Protect from light and moisture at all times
Usage Restrictions
For laboratory research use only
Not approved for human consumption, medical use, or diagnostic purposes
Handling should be performed by qualified professionals in controlled research settings
Store securely and keep out of reach of children
Do not handle during pregnancy or breastfeeding
Frequently Asked Questions
Q1. What does each vial contain? Each vial contains an 80mg four-peptide blend β GHK-Cu, KPV, BPC-157, and TB-500 β supplied as a sterile lyophilized powder.
Q2. What is the appearance of the product? A fine white to off-white (with a possible faint blue tint from the copper peptide) lyophilized powder at the base of the vial.
Q3. How should it be stored? Before reconstitution: store at β20Β°C, stable up to 24 months. After reconstitution: store refrigerated at 2β8Β°C, stable 2β3 weeks.
Q4. How is it reconstituted? It is soluble in sterile or bacteriostatic water. Use aseptic technique during reconstitution to maintain integrity.
Q5. Is it sterile? Yes, it is manufactured and sealed under sterile laboratory conditions. Proper sterile handling is still required during reconstitution and use.
Q6. Is this product for human use? No. This compound is intended for research use only. It is not approved for medical or veterinary use.
Q7. What purity standard is used? Every batch is HPLC-verified to β₯99% purity and third-party tested.
Q8. What is the vial packaging? A clear borosilicate glass vial sealed with a butyl rubber stopper and aluminum crimp closure.
Q9. How stable is the product during shipping? The lyophilized form is stable under standard shipping conditions. Transfer to long-term storage (β20Β°C) immediately upon arrival.
Q10. Who can handle this product? Only qualified laboratory researchers with appropriate training in peptide handling and proper protective equipment.





Reviews
There are no reviews yet.